(Q37858895)

24 August 2017

1 reference

title

Antiretroviral therapy: a key component of a comprehensive HIV prevention strategy (English)

1 reference

24 August 2017

0 references

anti-retroviral agent

0 references

prevention of HIV/AIDS

0 references

2

Julio Montaner

1 reference

24 August 2017

Mark W Hull

1

1 reference

24 August 2017

publication date

1 June 2011

1 reference

24 August 2017

published in

Current HIV/AIDS reports

1 reference

24 August 2017

volume

8

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

85-93

1 reference

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Survival of persons with and without HIV infection in Denmark, 1995-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Estimation of HIV incidence in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Correlation between HIV-1 RNA load in blood and seminal plasma depending on antiretroviral treatment status, regimen and penetration of semen by antiretroviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Discordance in HIV-1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Human immunodeficiency virus viral load in blood plasma and semen: review and implications of empirical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

HIV transmission risk among serodiscordant couples: a retrospective study of former plasma donors in Henan, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Modelling sexual transmission of HIV: testing the assumptions, validating the predictions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

A tale of two futures: HIV and antiretroviral therapy in San Francisco.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Treatment to prevent transmission of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

HIV-1 transmission, by stage of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Sexually acquired HIV infections in the United States due to acute-phase HIV transmission: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

No evidence of increased sexual risk behaviour after initiating antiretroviral therapy among people who inject drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Expanding access to HAART: a cost-effective approach for treating and preventing HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Behavioural strategies to reduce HIV transmission: how to make them work better

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Setting the stage: current state of affairs and major challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000???2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0076-6

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study

21 January 2018

1 reference

12 December 2020

Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study.

1 reference

12 December 2020

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

1 reference

12 December 2020

Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco

1 reference

12 December 2020

Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand

1 reference

12 December 2020

Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic

1 reference

12 December 2020

Sexual transmission of HIV-1.

1 reference

12 December 2020

Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC

1 reference

12 December 2020

Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California

1 reference

12 December 2020

Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis

1 reference

12 December 2020

Persistent HIV RNA shedding in semen despite effective antiretroviral therapy

1 reference

12 December 2020

Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis

1 reference

12 December 2020

Infectiousness of HIV-infected men who have sex with men in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

1 reference

12 December 2020

Differences between semen and plasma of nucleoside reverse transcriptase resistance mutations in HIV-infected patients, using a rapid assay

1 reference

12 December 2020

10.1007/S11904-011-0076-6

Identifiers

DOI

1 reference

24 August 2017

1 reference